Earnings Outlook For United Therapeutics

United Therapeutics (NASDAQ:UTHR) is gearing up to announce its quarterly earnings on Wednesday, 2024-10-30. Here's a quick overview of what investors should know before the release.

Analysts are estimating that United Therapeutics will report an earnings per share (EPS) of $6.42.

The announcement from United Therapeutics is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.

It's worth noting for new investors that guidance can be a key determinant of stock price movements.

Earnings Track Record

Last quarter the company missed EPS by $0.55, which was followed by a 4.63% increase in the share price the next day.

Here's a look at United Therapeutics's past performance and the resulting price change:

Quarter

Q2 2024

Q1 2024

Q4 2023

Q3 2023

EPS Estimate

6.40

5.65

4.19

5.08

EPS Actual

5.85

6.17

4.36

5.38

Price Change %

5.0%

1.0%

-1.0%

2.0%

Tracking United Therapeutics's Stock Performance

Shares of United Therapeutics were trading at $349.71 as of October 28. Over the last 52-week period, shares are up 56.66%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

Insights Shared by Analysts on United Therapeutics

For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding United Therapeutics.

A total of 6 analyst ratings have been received for United Therapeutics, with the consensus rating being Buy. The ...